Bobby SoniCBO at BioInnovation InstituteSpeaker
Profile
Bobby Soni is the Chief International Officer at the BioInnovation Institute (BII) responsible for expanding the BII Platform to new markets. Bobby has worked in early-stage innovation as a scientist at a biotech company (Maxygen), in pharma business development (LEO Pharma) and as an investor in Denmark and the UK (Novo Holdings and Imperial Innovations). At the BII. Bobby’s team has supported over 100 founder-led companies that have raised over 600M EUR in total external investment.
Agenda Sessions
"How Do You Do!": In collaboration with YVC - navigating mutual mentorship between CEOs and investors
, 17:00View Session